Effect of Hemodialysis and Peritoneal Dialysis on some Hematological and Biochemical Parameters in Renal Failure

Dara Khorshed Mohammad

doi:10.15218/zjms.2009.024

Authors

Dara Khorshed Mohammad University of Salahaddin, Erbil, College of Science, Department of Biology.

DOI:

https://doi.org/10.15218/zjms.2009.024

Keywords:

Renal failure patients, Haemodialysis, Peritonialdialysis, Anemia

Abstract

Background and objective: The purpose of the present study was to determine the effects of hemodialysis and peritoneal dialysis on some hematological and biochemical parameters in patients with renal failure on the dialysis.

Methods: Fifty two patients with renal failure were taken in this experiment on dialysis studied in the dialysis and kidney disease center in hawler teaching hospital, twenty six patients were taken for haemodialysis and the remaining patients were taken for the peritoneal dialysis process. Some hematological and biochemical parameters were taken before and after dialysis.

Results: In the Hemodialysis Patients: Hemoglobin concentration (Hb gm/dl), Red blood cells (RBCs x106/μl) and packed cell volume (PCV %) count, blood sugar (mg/dl), serum calcium (mg/dl), serum sodium (meq/L) and serum potassium (meq/L) were high significantly increased in patient with renal failure after hemodialysis in comparison before hemodialysis, while blood urea (mg/dl) were high significantly decreased in patient with renal failure after hemodialysis in comparison before hemodialysis. In the Peritoneal dialysis patients: Hb (gm/dl) and PCV (%) count, blood sugar (mg/dl) and serum calcium (mg/dl) were high significantly increased in patient with renal failure after peritoneal dialysis in comparison before peritoneal dialysis, while blood Urea (mg/dl) and serum Creatinine (mg/dl) were high significantly decreased in patient with renal failure after peritoneal dialysis in comparison before peritoneal dialysis, while there were non significant differences in serum sodium (meq/L) before and after peritoneal dialysis.

Conclusion: Hemodialysis significantly increases some RBC, Hb and PCV. Hemodialysis cause significantly decreases blood sugar and urea. Peritoneal dialysis significantly increases PCV and Hb. Peritoneal dialysis cause decreases the blood urea and blood sugar. Hemodialysis was more useful and gives good results than peritoneal dialysis.

Metrics

Metrics Loading ...

References

Major A. Mathez loic F., Rohling R. The effect of intravenous iron on the reticulocyte response to recombinant human erythropoietin. Br. J. Haematol 1997;98: 292-294.

Bergmann M, Grutzmacher P, Heuser J, Kaltwasser JP. Iron metabolism under repo therapy in patients on maintenance hemodilysis. Int J Artif Organ 1990; 13: 109-112.

Eschbach JW . The anemia of chronic renal failure: patho-physiology and the effect of recombinant erythropoietin. kidney Int 1985;35: 134-148.

Eschbach, J.W., Egrie J.C., Downing M.R., Browne J.K., Adamson J.W. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinicaltrial. N Engl J Med. 1987; 4; 323(14):999-1000.

Senger jm, Weiss RJ. Hematologic and erythropoietin responses to iron dextran in the hemodialysis environment. ANNA J 1996; 23: 319-323.

Sherman, A; Swartz, D. and Thomas, A. Treatment method for kidney failure hemodialysis, national kidney and urologic diseases information clearing house (INT). 2003.

Haen, P.J. Principle of haematology . W.M.C, Brown puplishers. 1995.

Varley, H. Practical clinical biochemistry. White friars press, Ltd. 1997.

Chawla, R. Practical clinical biochemistry: methods and interpretations. Jaypee Brothers Medical Publishers, Ltd. 2003.

Syiem, D; Syngai, G; Khup, P.Z; Khongwir, B.S; Kharbnli, B. and Kayang, H. Hypoglycemic effects of Potentillia fulgens L. in normal and alloxan-induced diabetic mice. Journal of Ethnopharmacology. 2002; 83: 51-56.

Anagnostou, A., Vercellotfi G., Borone, J. and Fried W. Factors Which Affect Erythropoiesis in Partially Nephrectomized and Sham-operated Rats Blood, 1976; Vol. 48, No. 3.

Kim, S. W., JongUn L., Dae G. K., Kwon J., Nam H. K., Soon P. S., Ki C. C., Young J. K. Erythropoietin does not affect nitric oxide system in rats with chronic renal failure. Korean Journal Medical Science. 2000; 15:183-188.

Muntzel, M., Thierry H., Bernard L. and Tilman D. Effect of Erythropoietin on Hematocrit and Blood Pressure in Normotensive and Hypertensive Rats. J. Am. Soc. Nephrol. 1992; 3:182-187.

Yanase, T., Maki T., Nawata H. Effect of angiotensin II on secretion of adrenal androgens. Endocrinol Jpn. 1984; 31:741–747.

Eschbach JW. Adamson JW .Anemia of end stage renal disease (ESRD) kidney Int. 1985; 28: 1-5

Adamson, J. W. The relationship of erythropoietin and iron metabolism to red blood cell production in humans. Semin Oncol. 1994; 21: 9-15.

Hawley, M. A. Normal and abnormal kidney function. Journal American Physiology. 2001; 5: 1-3.

Marrero, M. B., Venema R. C., Ma H., Ling B.N. and Eaton D.C. Erythropoietin receptor-operated Ca+2 channels: activation by phospholipase C-g1. Kidney Int. 1998; 53: 1259 –1268.

Cibulka, R., Racek, J. and vesela, E. The importance of L-carnitine in patients with chronic renal failure treated with hemodialysis. Vnitr Lek. 2005; 51:1108-1113.

Deray, G., Cacoub, P., Jacquiaud, C., Drobinski, M., Brillet, G., Bunker, D., Jaudon, M.C. and Jacobs, C. Renal Tolerance for loxalate in patients with Chronic Renal Failure. Radiology. 1991; 179:395-397.